Dr. Bernadette Ambrose Thomas, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1130 N 185th St Ste 201, Shoreline, WA 98133 Phone: 206-542-1000 Fax: 206-542-5353 |
Win Kyaw, M.D Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1130 N 185th St, Suite 102, Shoreline, WA 98133 Phone: 206-542-1000 Fax: 206-542-5353 |
Dr. Saw Hnin Mu, MD Internal Medicine - Nephrology Medicare: Medicare Enrolled Practice Location: 1130 N 185th St, Ste 201, Shoreline, WA 98133 Phone: 206-542-1000 Fax: 206-542-5353 |
Dr. Jung H Joh, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1130 N 185th St, Suite 102, Shoreline, WA 98133 Phone: 206-542-1000 Fax: 206-542-5353 |
Min Naing, M.D., Internal Medicine - Nephrology Medicare: Medicare Enrolled Practice Location: 1130 N 185th St Ste 201, Shoreline, WA 98133 Phone: 206-542-1000 Fax: 206-542-5353 |
News Archive
The American Thoracic Society applauds President Barack Obama and the Administration for the release of the National Action Plan to Combat Drug Resistant Tuberculosis (TB) today.
Evergreen Healthcare today announced that it has successfully integrated a colorectal procedure called transanal endoscopic microsurgery to its growing suite of minimally invasive surgical options, reducing the need for major surgery and providing patients with faster recovery times.
St. Jude Medical, Inc. today announced pilot study results from the first multi-center study investigating deep brain stimulation (DBS) of Brodmann Area 25 for major depressive disorder.
Researchers are conducting a clinical trial to help determine the best timing of delivery in preterm pregnancies complicated by poor fetal growth. Preliminary results from the trial, which are published early online in Ultrasound in Obstetrics & Gynecology, demonstrate better than expected health outcomes in this high-risk group of fetuses.
An international team of scientists including researchers at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute and the University of Southern California found that an enzyme commonly used as a target for antidepressants may also promote prostate cancer growth.
› Verified 5 days ago